These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 5718243)

  • 41. Hepatic cirrhosis in Jamaica.
    Williams NA; Lee MG; Hanchard B; Barrow KO
    West Indian Med J; 1997 Jun; 46(2):60-2. PubMed ID: 9260537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Uriz J; Cárdenas A; Arroyo V
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):927-43. PubMed ID: 11139347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal concentrating ability in cirrhosis. I. Changes associated with the clinical status and course of the disease.
    Vaamonde CA; Vaamonde LS; Morosi HJ; Klingler EL; Papper S
    J Lab Clin Med; 1967 Aug; 70(2):179-94. PubMed ID: 6029052
    [No Abstract]   [Full Text] [Related]  

  • 44. Cirrhosis of the liver in Japan.
    Yoshida T; Kawata H; Fukui O; Koizumi T; Asada M; Wada M
    Acta Hepatosplenol; 1965; 12(5):268-78. PubMed ID: 5866828
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical features and prognosis of decompensated hepatitis C virus related cirrhosis].
    Wu CH; Tian GS; Wang QH; Yu YY; Dou YQ; Xu XY
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):516-9. PubMed ID: 18649764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognostic factors in descompensated hepatic cirrhosis (I)].
    Santolaria Fernández F; Pestana Pestana M; González Reimers E; Batista López N; Jorge Hernández J; González Martín I; Hernández Nieto L
    Rev Clin Esp; 1984 Jan; 172(1):27-30. PubMed ID: 6608770
    [No Abstract]   [Full Text] [Related]  

  • 48. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ascites in Ethiopian patients: a preliminary study.
    Lester FT; Tsega E
    Ethiop Med J; 1975 Oct; 13(4):137-46. PubMed ID: 1233153
    [No Abstract]   [Full Text] [Related]  

  • 51. [Predictive analysis of the response to treatment with diuretics of patients with liver cirrhosis and ascites].
    Del Val A; Garrrigues V; Ponce J; Berenguer J
    Rev Esp Enferm Dig; 1995 Dec; 87(12):859-64. PubMed ID: 8562191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ammonia tolerance test used to differentiate between ascites of cirrhotic and malignant genesis.
    Felding C; Christensen RF; Lindahl F
    Scand J Gastroenterol; 1984 May; 19(3):365-8. PubMed ID: 6740212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The hepatorenal syndrome in hepatic cirrhosis: risk factors and evolution].
    Buligescu L; Costandache M; Moscaliu I; Copaci I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(4):349-55. PubMed ID: 6131518
    [No Abstract]   [Full Text] [Related]  

  • 54. Serum hyaluronan as a possible biomarker of liver insufficiency in cirrhotic patients.
    Grzeszczuk A; Chlabicz S; Panasiuk A
    Rocz Akad Med Bialymst; 2002; 47():80-5. PubMed ID: 12533949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spontaneous chylous ascites of cirrhosis.
    Rector WG
    J Clin Gastroenterol; 1984 Aug; 6(4):369-72. PubMed ID: 6481122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Observations on a case of liver cirrhosis in its terminal phase].
    Migneco G; Mascarella A; Tripi S; La Cascia C; Di Caro R
    Clin Ter; 1984 Sep; 110(6):587-9. PubMed ID: 6238772
    [No Abstract]   [Full Text] [Related]  

  • 57. [Our isotopic functional values in liver cirrhosis].
    De La Rosa Pozuelo JA; Sanz García D
    Rev Clin Esp; 1976 Apr; 141(2):139-43. PubMed ID: 935579
    [No Abstract]   [Full Text] [Related]  

  • 58. [Contribution to the etiopathogenesis of the hepatocerebral syndrome. Activity of glutamic-oxaloacetic aminotransferase].
    Gostof R; Englis M; Vidová O
    Cesk Pediatr; 1969 Dec; 24(12):1057-61. PubMed ID: 5362966
    [No Abstract]   [Full Text] [Related]  

  • 59. [Current status of the treatment of liver cirrhosis].
    Paccalin J
    Bord Med; 1971 Oct; 4(10):2869-87. PubMed ID: 5132516
    [No Abstract]   [Full Text] [Related]  

  • 60. [Embolization of hepatic artery in liver cirrhosis complicated by ascites: long-term results].
    Tarazov PG
    Khirurgiia (Mosk); 1999; (4):18-21. PubMed ID: 10234903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.